Dr. Jamieson on Symptom Management in Myelofibrosis

Catriona Jamieson, MD, PhD, discusses symptom management in patients with myelofibrosis.

Catriona Jamieson, MD, PhD, the team leader for the Division of Hematology/Oncology at UC San Diego Health Moores Cancer Center, discusses symptom management in patients with myelofibrosis.

The best way to manage symptom burden for this patient population is to choose the appropriate treatment regimen, according to Jamieson. Previously, treatment options were limited for patients with myelofibrosis, and a larger focus was put on managing their quality of life vs their quantity of life, Jamieson says. However, these 2 factors are, in fact, intertwined, Jamieson notes. 

With the advent of better treatments that more effectively target the disease, both outcomes and symptoms have improved for patients, Jamieson explains. Currently, 2 FDA-approved agents are available for use in this population, but many promising agents are in the pipeline; these options will help to shift the focus in care from symptom management to disease modification for patients, Jamieson concludes.

Related Videos
Brian Henick, MD
Abhinav Deol, MD
Veronika Bachanova, MD, PhD
Walter M. Stadler, MD
Susan Domchek, MD, FASCO
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Amy L. Cummings, MD, thoracic oncologist, assistant professor of medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center
Aaron Gerds, MD, an expert on myeloproliferative neoplasms
Aaron Gerds, MD, an expert on myeloproliferative neoplasms
Amandeep Godara, MBBS
Related Content